CVS Health Corp (CVS) Price

CVS Health Signals Shift to Value-Based Care Model

CVS Health executive Sree Chaguturu promoted a shift to value-based care, calling the current fee-for-service model 'broken' as the company's stock fell 0.52%.

CVS Health Stock Analysis Shows Uncertain Outlook

An analysis of trending stock CVS Health (CVS) reveals an uncertain outlook with no significant event or catalyst to drive a clear buy or sell decision.

CVS Health Boosts Guidance, Takes $5.7B Impairment

CVS Health raised its 2025 revenue guidance to at least $400 billion while also forecasting a US$5.73 billion goodwill impairment charge for December 2025.

Oscar Health Stock Gains as GOP Division Imperils ACA Subsidies

Oscar Health stock rallied on Wednesday, December 17, while competitors Centene and HCA Healthcare declined following a Republican announcement that could block the extension of ACA subsidies.

Molina Healthcare Outgrows CVS, Masimo on Strong Revenue Growth

StockStory analysis highlights Molina Healthcare's (MOH) 19.3% annual revenue growth over five years, while cautioning against Masimo (MASI) for its 16.3% sales decline and CVS Health (CVS) for its 2.9% annual EPS drop.

Abbott Labs Shows Financial Health Amid Sector Volatility

Abbott Laboratories showcases a strong balance sheet with reduced debt and high interest coverage, presenting a stable profile amid a volatile healthcare sector focused on obesity drugs and policy shifts.

Merck Lifts Dividend, Boosting Shareholder Payout

Merck announced an increased dividend to $0.85 per share, creating a 3.4% forward yield. The move signals confidence in its financial stability and commitment to shareholder returns, even as the company faces a new FDA safety review for its RSV antibody treatment, Enflonsia.

Managed Care Stocks Rise Amid Subsidy Debate

Health insurance stocks, including UnitedHealth and Centene, gained as the U.S. House considers a vote on extending Affordable Care Act (ACA) subsidies set to expire. Legislative uncertainty persists, but market participants are reacting to signs of potential action that would preserve coverage for approximately 24 million Americans.

Healthcare Stocks Face Policy, Pipeline Headwinds

U.S. healthcare and pharmaceutical stocks are facing a period of heightened volatility driven by the obesity drug arms race, shifting U.S. policy on healthcare subsidies, and an increasingly dual-natured FDA that is both accelerating approvals and intensifying safety scrutinies. These factors create a complex investment landscape heading into the week of December 15, 2025.

Cramer Urges Caution On Dow Inc. Upside

Jim Cramer expressed a cautious "hold" stance on Dow Inc., suggesting limited short-term gains of only a point or two. His commentary highlights a selective investor approach, weighing company-specific potential against broader market trends where other sectors are seeing more bullish analyst ratings.

Novo Nordisk India Launch Exposes Price Disparity

Novo Nordisk has launched Ozempic in India at a price point dramatically lower than in the U.S., signaling a strategic move to penetrate emerging markets with a tiered pricing model. This highlights the vast price disparities for GLP-1 drugs globally and may increase pressure on competitors.

Insurers’ Pricing Models Clash With Opaque System

New drug pricing models from major insurers promise simplicity but face significant headwinds from a persistently complex and non-transparent healthcare system, leaving the potential for meaningful cost reductions uncertain.

CVS Health Boosts Guidance With New AI Platform

CVS Health has raised its financial outlook for 2025 and provided a preliminary positive forecast for 2026, driven by strong performance in its Aetna and pharmacy benefits divisions and the launch of a new AI-powered consumer health platform.

CDC Data Bolsters Pediatric Vaccine Outlook

A new Centers for Disease Control and Prevention (CDC) report validates the effectiveness of 2024–2025 COVID-19 vaccines in children. This data provides a strong, evidence-based counterpoint to vaccine hesitancy amid ongoing public health challenges like the measles outbreak in South Carolina.

CVS Stock Gains on Bullish Outlook

CVS Health Corp. stock rose 2% following positive commentary from media personality Jim Cramer and the announcement of bullish long-term earnings targets by company management, signaling renewed investor confidence in the healthcare giant.

Adobe Earnings to Test AI Monetization Strategy

Adobe is set to release its Q4 fiscal 2025 earnings, with investors closely monitoring the financial impact of its new artificial intelligence features. The report follows a 10% rise in Adobe's stock, fueled by optimism surrounding its AI strategy and strong performance from competitors like Salesforce.

Zacks Analysis Favors Axis Capital (AXS) Over Cincinnati Financial (CINF) on Key Value Metrics